Changes in <i>qnr</i> Prevalence and Fluoroquinolone Resistance in Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Enterobacter</i> spp. Collected from 1990 to 2005Jacob Strahilevitz, Ari Robicsek, Dalia Engelstein et al.|Antimicrobial Agents and Chemotherapy|2007Cited by 47
Serogroup A<i>Neisseria meningitidis</i>with Reduced Susceptibility to CiprofloxacinJacob Strahilevitz, Colin Block, Amos Adler et al.|Emerging infectious diseases|2008Cited by 32
KPC-9, a Novel Carbapenemase from Clinical Specimens in IsraelCarlos Hidalgo‐Grass, Jacob Strahilevitz, Gabriela Warburg et al.|Antimicrobial Agents and Chemotherapy|2012Cited by 26
Bacteremia with Carbapenemase-Producing <i>Enterobacterales</i> in Immunocompromised Patients Colonized with These BacteriaDiana Averbuch, Jacob Strahilevitz, Liya Moshkovitz et al.|Microbial Drug Resistance|2022Cited by 10
<i>In vivo</i> selection of carbapenem resistance during persistent <i>Klebsiella pneumoniae</i> sequence type 395 bloodstream infection due to OmpK36 deletionJacob Strahilevitz, Jacob Moran‐Gilad, Margaret M. C. Lam et al.|Antimicrobial Agents and Chemotherapy|2024Cited by 6